Iran Bio Congress
Actover Group, sponsor of the Iranian national wrestling teams as well as the large family of wrestling
Appreciation of country’s medalists and champions of wrestling at the Tokyo Olympics
Dr. Shahriari’s visit of Sputnik V vaccine production lines
According to the public relations of the Actover group, Dr. Shahriari, the head of the health commission of the Parliament of Iran, together with some members of the parliament and the accompanying delegation, visited the production lines of the Russian Sputnik vaccine at the Actoverco’s factory.
Production of more the 600 thousands of Remdesivir vials
“Currently, about 6 million people in the country are constantly taking various drugs of Actoverco” said the director of the Actoverco’s factory.
Inauguration of Actotech pharmaceutical and food accelerator with the presence of Dr. Sattari, Vice President for Science and Technology
According to the public relations of the Actover Group, Dr. Ali Naraghi at the opening of the pharmaceutical and food accelerator said: “This Corporation is the result of thinking about creation of a link between industry and the university.
Actoverco’s attendance at the 9th scientific conference of Diabetes in practice
The 19th Iranian Congress of Gastroenterology and Hepatology was held from November 6 to 8 at the Razi International Conference Center.
We will fulfill our mission
the senior marketing and sales manager of Actero said: “Actero Pharmaceutical factory specialized in the production of cancer drugs and one of the six subcategories of Actover Holding, by the end of this year and operating its solid and injectable drugs production lines.
Interview with the CEO of Actoverco
According to the public relations of Actover Group, Nahaleh Naraghi is the CEO of Actoverco. Actoverco is a leading company in the field of producing high quality drugs in accordance with the latest international standards.
Application of CPB technology in production of Actoverco’s Interferon beta 1-a
According to Actoverco’s Public Relations, we are currently producing the raw material of interferon beta-1a from the cell line in the Actover Group in the Actoverco Biotech factory.
The presence of Actover Pharmaceutical Group in the 2nd Pharmex Middle East Festival
Actover Group with more than 250 products and 2500 employees with 5 factories production lines in 15 therapeutic areas in various parts of production, marketing and distribution it is one of the largest manufacturers of drugs in Iran and the Middle East.
Remote working at Actoverco due to COVID-19
According to Actoverco’s Public Relations, to prevent the risk of a new coronavirus (COVID-19) and its spread, the Actover Drug and Food Industry Group has implemented a remote working protocol for its staff.
Four great achievements
efforts of the children of Iran in the Actover Pharmaceutical Group, four great achievements in the current situation are presented as a drop from the boundless sea of service to the noble people of our country.